Bristol-Myers Squibb's (NYSE:BMY) short percent of float has fallen 29.89% since its last report. The company recently reported that it has 27.33 million shares sold short, which...
Here's a roundup of top developments in the biotech space over the last 24 hours:Stocks In FocusBausch Health To Appeal Expected Court Decision On Xifaxan PatentsBausch Health...
Here's a roundup of top developments in the biotech space over the last 24 hours:Stocks In FocusBausch Health To Appeal Expected Court Decision On Xifaxan PatentsBausch Health...
Despite stock market declines, 65 new ETFs were listed in Q2Fidelity has over $30 billion in assets under management3 ETFs for investors looking to diversify portfolios There...
Bristol Myers Squibb came out with quarterly earnings of $1.93 per share.
Bristol Myers Squibb is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2022.
Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. The Company’s pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company’s products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Buy | Buy |
| Technical Indicators | Buy | Strong Buy | Strong Buy | Sell | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Neutral | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 1,769.00 | 1,879.00 | 1,760.00 | -96.00 | -5.15% | 258.63K | London | |||
| 1,250.50 | 1,260.00 | 1,226.00 | +28.00 | +2.29% | 819.22K | London | |||
| 2,100.00 | 2,165.00 | 2,100.00 | -50.00 | -2.33% | 114.38K | London | |||
| 95.50 | 97.90 | 94.10 | +0.30 | +0.32% | 145.09K | London | |||
| 92.30 | 92.80 | 91.50 | +0.80 | +0.87% | 153.96K | London | |||
| 4,536.00 | 4,625.00 | 4,536.00 | +3.0 | +0.07% | 482.58K | London | |||
| 172.95 | 172.95 | 167.75 | +5.80 | +3.47% | 6.60M | London | |||
| 67.90 | 70.30 | 66.90 | -0.70 | -1.02% | 1.30M | London | |||
| 254.10 | 256.30 | 252.30 | +0.90 | +0.35% | 7.12M | London | |||
| 121.02 | 122.02 | 120.14 | -0.42 | -0.35% | 55.45M | London | |||
| 410.10 | 410.30 | 403.30 | +8.10 | +2.02% | 4.54M | London | |||
| 3,270.00 | 3,291.00 | 3,247.00 | +13.0 | +0.40% | 2.37M | London | |||
| 368.00 | 370.00 | 360.00 | +7.50 | +2.08% | 241.86K | London | |||
| 276.40 | 285.10 | 272.50 | -3.50 | -1.25% | 2.99M | London | |||
| 2.10 | 2.10 | 2.10 | 0.00 | 0.00% | 1.78M | London |